4//SEC Filing
Schroeder Mark S 4
Accession 0001127602-25-003716
CIK 0000920148other
Filed
Feb 9, 7:00 PM ET
Accepted
Feb 10, 9:15 AM ET
Size
19.2 KB
Accession
0001127602-25-003716
Insider Transaction Report
Form 4
Schroeder Mark S
EVP, Pres Diagnostics & COO
Transactions
- Tax Payment
Common Stock
2025-02-06$247.74/sh−210$52,025→ 5,569.143 total - Exercise/Conversion
Common Stock
2025-02-07+517→ 6,086.143 total - Exercise/Conversion
Common Stock
2025-02-07+164→ 6,104.143 total - Tax Payment
Common Stock
2025-02-07$246.27/sh−47$11,575→ 6,057.143 total - Exercise/Conversion
Restricted Stock Unit
2025-02-07−517→ 2,805 total→ Common Stock (517 underlying) - Exercise/Conversion
Restricted Stock Unit
2025-02-07−164→ 2,641 total→ Common Stock (164 underlying) - Exercise/Conversion
Common Stock
2025-02-06+743→ 5,779.143 total - Tax Payment
Common Stock
2025-02-07$246.27/sh−146$35,955→ 5,940.143 total - Exercise/Conversion
Restricted Stock Unit
2025-02-06−743→ 3,322 total→ Common Stock (743 underlying)
Footnotes (5)
- [F1]Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. ("LHI") Common Stock.
- [F2]Stock withholding to satisfy tax withholding obligations.
- [F3]The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 6, 2025.
- [F4]This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
- [F5]The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 7, 2024.
Documents
Issuer
LABCORP HOLDINGS INC.
CIK 0000920148
Entity typeother
Related Parties
1- filerCIK 0001793112
Filing Metadata
- Form type
- 4
- Filed
- Feb 9, 7:00 PM ET
- Accepted
- Feb 10, 9:15 AM ET
- Size
- 19.2 KB